Comparative Analysis of Established Risk Scores and Novel Hemodynamic Metrics in Predicting Right Ventricular Failure in Left Ventricular Assist Device Patients
Left ventricular assist devices (LVADs) have become an important cornerstone in the management of advanced heart failure (HF) patients. These devices have alleviated the unacceptable mortality that was previously observed in advanced HF, particularly in those waiting on the heart transplant list.1 Despite the widespread adoption and success of LVADs for bridge-to-transplant or destination therapy indications, several attendant complications continue to limit the efficacy of LVADs.2,3 The prevention and management of certain complications such as bleeding, hemolysis, stroke and driveline infections has fortunately improved, particularly with the newer generation LVADs.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Anthony E. Peters, LaVone A. Smith, Priscilla Ababio, Khadijah Breathett, Timothy L. McMurry, Jamie L.W. Kennedy, Mohammad Abuannadi, James Bergin, Sula Mazimba Tags: Clinical Investigation Source Type: research
More News: Bleeding | Cardiology | Heart | Heart Failure | Heart Transplant | Stroke | Transplant Surgery | Transplants